BRCA1 4153delA founder mutation in Russian ovarian cancer patients

<p>Abstract</p> <p>The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial and/or early...

Full description

Bibliographic Details
Main Authors: Krylova Nadezhda, Lobeiko Oksana S, Sokolenko Anna P, Iyevleva Aglaya G, Rozanov Maxim E, Mitiushkina Natalia V, Gergova Madina M, Porhanova Tatiana V, Urmancheyeva Adel F, Maximov Sergey, Togo Alexandr V, Imyanitov Evgeny N
Format: Article
Language:English
Published: BMC 2006-09-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Online Access:http://www.hccpjournal.com/content/4/4/193
_version_ 1811294309367939072
author Krylova Nadezhda
Lobeiko Oksana S
Sokolenko Anna P
Iyevleva Aglaya G
Rozanov Maxim E
Mitiushkina Natalia V
Gergova Madina M
Porhanova Tatiana V
Urmancheyeva Adel F
Maximov Sergey
Togo Alexandr V
Imyanitov Evgeny N
author_facet Krylova Nadezhda
Lobeiko Oksana S
Sokolenko Anna P
Iyevleva Aglaya G
Rozanov Maxim E
Mitiushkina Natalia V
Gergova Madina M
Porhanova Tatiana V
Urmancheyeva Adel F
Maximov Sergey
Togo Alexandr V
Imyanitov Evgeny N
author_sort Krylova Nadezhda
collection DOAJ
description <p>Abstract</p> <p>The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial and/or early-onset and/or bilateral Russian breast cancer (BC) patients. Since literature data suggest that the 4153delA variant is more associated with ovarian cancer (OC) than with BC, we expected to reveal a highly elevated frequency of this genotype in Russian ovarian cancer series. However, real-time allele-specific PCR genotyping has detected only two BRCA1 4153delA carriers out of 177 unselected OC patients (1.1%). Both these carriers were early-onset and had serous carcinomas of grade 3. Thus, our study supports neither the Russian origin of BRCA1 4153delA mutation, nor its selectivity towards ovarian <it>versus </it>breast cancer predisposition.</p>
first_indexed 2024-04-13T05:14:34Z
format Article
id doaj.art-59f420f9b52041e888275da6e8cbb3b8
institution Directory Open Access Journal
issn 1897-4287
language English
last_indexed 2024-04-13T05:14:34Z
publishDate 2006-09-01
publisher BMC
record_format Article
series Hereditary Cancer in Clinical Practice
spelling doaj.art-59f420f9b52041e888275da6e8cbb3b82022-12-22T03:00:55ZengBMCHereditary Cancer in Clinical Practice1897-42872006-09-014419319610.1186/1897-4287-4-4-193BRCA1 4153delA founder mutation in Russian ovarian cancer patientsKrylova NadezhdaLobeiko Oksana SSokolenko Anna PIyevleva Aglaya GRozanov Maxim EMitiushkina Natalia VGergova Madina MPorhanova Tatiana VUrmancheyeva Adel FMaximov SergeyTogo Alexandr VImyanitov Evgeny N<p>Abstract</p> <p>The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial and/or early-onset and/or bilateral Russian breast cancer (BC) patients. Since literature data suggest that the 4153delA variant is more associated with ovarian cancer (OC) than with BC, we expected to reveal a highly elevated frequency of this genotype in Russian ovarian cancer series. However, real-time allele-specific PCR genotyping has detected only two BRCA1 4153delA carriers out of 177 unselected OC patients (1.1%). Both these carriers were early-onset and had serous carcinomas of grade 3. Thus, our study supports neither the Russian origin of BRCA1 4153delA mutation, nor its selectivity towards ovarian <it>versus </it>breast cancer predisposition.</p>http://www.hccpjournal.com/content/4/4/193BRCA1ovarian cancerfounder mutationhereditary cancer
spellingShingle Krylova Nadezhda
Lobeiko Oksana S
Sokolenko Anna P
Iyevleva Aglaya G
Rozanov Maxim E
Mitiushkina Natalia V
Gergova Madina M
Porhanova Tatiana V
Urmancheyeva Adel F
Maximov Sergey
Togo Alexandr V
Imyanitov Evgeny N
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Hereditary Cancer in Clinical Practice
BRCA1
ovarian cancer
founder mutation
hereditary cancer
title BRCA1 4153delA founder mutation in Russian ovarian cancer patients
title_full BRCA1 4153delA founder mutation in Russian ovarian cancer patients
title_fullStr BRCA1 4153delA founder mutation in Russian ovarian cancer patients
title_full_unstemmed BRCA1 4153delA founder mutation in Russian ovarian cancer patients
title_short BRCA1 4153delA founder mutation in Russian ovarian cancer patients
title_sort brca1 4153dela founder mutation in russian ovarian cancer patients
topic BRCA1
ovarian cancer
founder mutation
hereditary cancer
url http://www.hccpjournal.com/content/4/4/193
work_keys_str_mv AT krylovanadezhda brca14153delafoundermutationinrussianovariancancerpatients
AT lobeikooksanas brca14153delafoundermutationinrussianovariancancerpatients
AT sokolenkoannap brca14153delafoundermutationinrussianovariancancerpatients
AT iyevlevaaglayag brca14153delafoundermutationinrussianovariancancerpatients
AT rozanovmaxime brca14153delafoundermutationinrussianovariancancerpatients
AT mitiushkinanataliav brca14153delafoundermutationinrussianovariancancerpatients
AT gergovamadinam brca14153delafoundermutationinrussianovariancancerpatients
AT porhanovatatianav brca14153delafoundermutationinrussianovariancancerpatients
AT urmancheyevaadelf brca14153delafoundermutationinrussianovariancancerpatients
AT maximovsergey brca14153delafoundermutationinrussianovariancancerpatients
AT togoalexandrv brca14153delafoundermutationinrussianovariancancerpatients
AT imyanitovevgenyn brca14153delafoundermutationinrussianovariancancerpatients